More News

Partnership to discover small-molecule therapeutics

DeepLife, a Paris-based techbio company developing AI-powered digital twins of human cells, and 3billion, an AI-powered genomics company specialising...

New Sjögren’s disease study data

Johnson & Johnson has announced new patient experience findings from the phase 2 DAHLIAS study of nipocalimab in Sjögren's...

Macrophage activation syndrome study data published

TJ Biopharma has announced the publication of results from PRIME-1, a phase 2 study of plonmarlimab in macrophage activation...

European patent for fibroblast delivery of tumour inhibitory agents

FibroBiologics, Inc. has announced that the European Patent Office has granted European Patent "Fibroblast Delivery of Tumor Inhibitory Agents." The...

Obesity drugs could lead to new ways to protect the brain

Drugs used to treat obesity may also help protect the brain. In a review published in Science, researchers describe...

Data support bladder-preserving alternative to radical cystectomy

Combat Medical has announced new data showing 68% high-grade recurrence-free survival (HG-RFS) at 12 months in patients with Bacillus...

Molecular switch triggers inflammation

Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular...

Shilpa CDMO to invest $50m in commercial peptide manufacturing

Shilpa CDMO is investing $50m to expand its peptide manufacturing capabilities as global demand accelerates for GLP-1s and a...

Unnatural Products to be acquired by argenx in $1.15bn deal

Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, has entered into a...

“Significant improvement” in psoriatic arthritis disease activity with oral peptide

Johnson & Johnson has announced positive results from a phase 3 study investigating ICOTYDE (icotrokinra) in biologic-naïve adults with...

Is synthetic DNA tomorrow’s hard drive?

Every day we generate enormous amounts of data. And the rise of artificial intelligence has increased that output. The question...

Base to Base biotech podcast 83: Different approaches to beating cancer tumours

This week, we have a conversation with Valerie Vanhooren, CEO and co-founder of Ona Therapeutics about first-in-class ADCs for...

Data for MDM2 inhibitor announced

Lamassu Biotech has announced initial safety and pharmacokinetic data from the ongoing first-in-human phase 1/2a clinical trial (LB-SA53-101) of...

Transpharmation acquiring OrganoTherapeutics

Transpharmation Ltd. has announced the acquisition of OrganoTherapeutics SARL, a provider of patient-derived organoid technologies that advance the discovery...

Astrosalva Therapeutics born to beat Alexander disease and cALD

Astrosalva Therapeutics, Inc. has launched to develop treatments for Alexander disease and the cerebral form of adrenoleukodystrophy (cALD). Unravel Biosciences,...

Ageing study shows promising effects of supplement on vascular health biomarkers

A multi-component nutritional supplement has been found to improve markers of vascular health, in a randomised controlled trial led...

New transport pathway shows promise for brain drug delivery

Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues...

MEPSGEN debuts system for small-volume nanoparticle formulation

MEPSGEN US, Inc. has launched the NanoCalibur Mini, an automated system for small-volume nanoparticle formulation designed for early-stage drug...

Positive results from extensive-stage small cell lung cancer study

Shanghai Henlius Biotech, Inc has announced positive results from ASTRIDE, a randomised, descriptive, open-label, US study of serplulimab (in...

ALLOX raises $10.5m to scale allosteric drug discovery platform and build pipeline

ALLOX, a biotechnology company developing a high-throughput, experimental-first platform to discover and exploit allosteric sites and other regulatory regions...

Worm study may have implications for Alzheimer’s and Huntington’s

A new study has discovered that reducing a cellular process called UFMylation helped worms better cope with toxic protein...